Why every ED brand now sells a “custom” blend

Sildenafil went generic in 2017 and tadalafil in 2018. Both now cost a few dollars a month. That should have been the end of the story — a solved problem, cheaply.

Instead, nearly every direct-to-consumer ED brand has spent the years since moving customers off those generics and onto its own compounded formulations: chewable mints, sublingual drops, gummies, and liquids combining several drugs at once. This piece is about why that happened, and what it means for what you are swallowing.

What compounded actually means

A compounded drug is prepared by a pharmacy rather than manufactured under an FDA-approved application. The distinction is not cosmetic.

The sellers generally say this outright. One states it plainly: *“Compounded drugs are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.”* That disclosure is accurate and appears on most of these sites. The question is whether anyone reads it as the significant statement it is.

The rule that shapes every one of these products

Here is the piece that explains the whole pattern, and it is a regulatory one rather than a medical one.

Federal law generally bars a compounding pharmacy from producing a drug that is essentially a copy of a commercially available FDA-approved product. A pharmacy cannot simply mass-produce sildenafil tablets and undercut the approved generic.

Read the formulations with that in mind and they stop looking like pharmacology and start looking like product design.

What is actually being sold

Three things stand out across that list, and each is worth taking separately.

1. Stacking PDE5 inhibitors

The marketing logic is easy to follow — pair a fast-onset drug with a long-acting one and advertise both properties. The pharmacological logic is weaker, because tadalafil already lasts up to 36 hours by itself, and avanafil already works in about 15 minutes by itself. Both are single approved drugs with printed doses.

2. Apomorphine

A dopamine agonist that turns up in several of these blends. It has a history worth knowing: sublingual apomorphine was genuinely developed for erectile dysfunction and approved in Europe as Uprima, then withdrawn from the market, and it was never approved for ED in the United States.

The reasons were prominent nausea and vomiting, dizziness, low blood pressure, and fainting. It also interacts dangerously with ondansetron and similar anti-nausea drugs, causing profound hypotension. Adding a hypotensive agent on top of two or three PDE5 inhibitors runs against the usual justification for combining drugs, which is to use less of each.

3. Ingredients that do nothing

Vitamin B12 has no established role in erectile function. Oxytocin has no established oral or sublingual role in treating ED, and is poorly absorbed by mouth in any case.

What an inert or unproven additive does accomplish is make the formulation something other than a copy of an approved drug. That is the function it serves, and it is a regulatory function rather than a clinical one.

The doses are frequently not published

This is the part that should trouble you most, and it is startlingly common. For several of the products above, no dose is stated anywhere a prospective customer can see it.

If you are prescribed one of these, ask for the exact strength of every active ingredient in writing, and give it to whoever manages your regular care.

Why this is happening now

Follow the commercial pressure and it is entirely predictable.

1. 1Generics destroyed the margin. Sildenafil and tadalafil cost almost nothing to produce and are stocked everywhere.
2. 2Approved drugs are price-comparable. You can check the price of generic sildenafil across ten pharmacies in five minutes.
3. 3A proprietary blend cannot be compared to anything, because nothing else is like it.
4. 4Compounding permits combinations no manufacturer can sell, since the required trials do not exist and are not demanded.
5. 5The disclaimer is cheap. Saying “not FDA-approved” in small type costs nothing and satisfies the requirement.

What to ask before accepting one

1. 1What is the exact dose of every active ingredient? Get it in writing. A refusal is an answer.
2. 2Is this FDA-approved, or compounded? Both may be offered; the cheaper option is often the approved one.
3. 3Which compounding pharmacy makes it, and is it state-licensed and in good standing?
4. 4Does it contain more than one PDE5 inhibitor? If so, ask the prescriber to justify that specifically.
5. 5What is the cost per dose, against generic sildenafil at a local pharmacy with a discount card?
6. 6Would a single approved drug achieve what I actually want? Usually the answer is yes.

The simplest version of all this

If you want an ED medication to work faster, there is an approved drug for that. If you want one to last longer, there is an approved drug for that too. Both print their dose on the box, have been tested in trials involving tens of thousands of people, carry mandatory interaction warnings, and cost a few dollars a month as generics.

A compounded blend is worth choosing when it does something an approved product genuinely cannot — a format you truly need, or a combination with real clinical rationale behind it. It is not worth choosing because the marketing was better. See what ED medication should actually cost and our provider reviews for who sells what.